| Adolescent and Young Adult Cancer Survivors: Identity Development (NCT00832325) | Memorial Sloan Kettering Cancer Center | 2009-01-01 |
| Predictive Value of Drug Elimination Gene Polymorphisms on Clearance and Dose Adjustment of Sunitinib in Cancer Patients (NCT01098903) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2009-01-01 |
| Identifying Therapeutic Factors in an 8-Week (30 Hour) Mindfulness-Based Stress Reduction (MBSR) Program (NCT01599143) | North York General Hospital | 2009-01-01 |
| AMG386 Comb w. Either Pegylated Liposomal Doxorubicin or Topotecan Subjects w. Advanced Recurrent Epithelial Ovarian CR (NCT00770536) | Amgen | 2009-01-01 |
| M. D. Anderson Symptom Inventory - Heart Failure (MDASI-HF) Symptom Management Program (NCT00827801) | M.D. Anderson Cancer Center | 2009-01-01 |
| Genetic Susceptibility and Risk of Second Cancers in Patients Who Have Undergone Stem Cell Transplant for Cancer (NCT00949052) | Vanderbilt-Ingram Cancer Center | 2009-01-01 |
| The Effects of Aggressive Patient Management on Cancer Therapy Management (NCT00962572) | University of Mississippi Medical Center | 2009-01-01 |
| African American Cancer Prevention Project: Establishing a Cohort to Investigate Health Disparities (NCT00823394) | M.D. Anderson Cancer Center | 2008-12-05 |
| Iron Overload in Patients Undergoing Donor Stem Cell Transplant (NCT00888316) | Masonic Cancer Center, University of Minnesota | 2008-12-01 |
| A Multicenter Phase I Clinical Study of a New Compound P1446A-05 in Patients With Advanced Refractory Malignancies (NCT00772876) | Piramal Enterprises Limited | 2008-12-01 |
| A Phase 1 Study of AMG 208 in Subjects With Advanced Solid Tumors (NCT00813384) | Amgen | 2008-12-01 |
| Microculture Kinetic (MiCK) Apoptosis Test Results With Drug Treatment Results in Cancer Patients (NCT00901264) | Pierian Biosciences | 2008-12-01 |
| Anderson Circulating Tumor Cell Burden (CTCB) Study (NCT00819832) | M.D. Anderson Cancer Center | 2008-12-01 |
| Management of Bone Defects Around the Elbow (NCT00873145) | Medical University of Vienna | 2008-12-01 |
| CASIMAS: Catumaxomab Safety Phase IIIb Study With Intraperitoneal Infusion in Patients With Malignant Ascites Due to Epithelial Cancers (NCT00822809) | Neovii Biotech | 2008-12-01 |
| A Study Of PF-04554878 In Patients With Advanced Non-Hematologic Malignancies (NCT00787033) | Verastem, Inc. | 2008-12-01 |
| Outlook Quality of Life Intervention (NCT00784095) | VA Office of Research and Development | 2008-12-01 |
| Phase I Study to Determine the Maximum Tolerate Dose (MTD) of BGT226 in Advanced Solid Tumors in Japan (NCT00742105) | Novartis Pharmaceuticals | 2008-11-17 |
| Community Cancer Centers Pilot Patient Survey (NCT00786656) | National Cancer Institute (NCI) | 2008-11-03 |
| Compassionate Use of Mifepristone in Brain/Nervous System and Other Cancers (NCT00832871) | New Mexico Cancer Research Alliance | 2008-11-01 |
| A Phase 2, Randomized, Double Blind, Placebo Controlled Study of AMG 386 in Combination With FOLFIRI in Subjects With Previously Treated Metastatic Colorectal Carcinoma (NCT00752570) | Amgen | 2008-11-01 |
| Burden of Cancer in Children: A Pilot Study to Investigate the Impact and Content of Video Illness Narratives (NCT00793299) | University of Rochester | 2008-11-01 |
| Chronic Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant (NCT00957736) | Vanderbilt-Ingram Cancer Center | 2008-11-01 |
| Phase 2 Study of Tapentadol Prolonged Release in Cancer Pain Participants (NCT00805142) | Janssen Pharmaceutical K.K. | 2008-11-01 |
| Phase II Study of SOM230 in Patients With Recurrent or Progressive Meningioma (NCT00813592) | University of Utah | 2008-11-01 |
| Sorafenib-RT Treatment for Liver Metastasis (SLIM) (NCT00892424) | University Health Network, Toronto | 2008-11-01 |
| Safety Study of Pharmacokinetics of XL888 in Adults With Solid Tumors (NCT00796484) | Exelixis | 2008-11-01 |
| Symptom Clusters in Cancer Patients and Their Caregivers- a Longitudinal Study (NCT00769301) | Oslo University Hospital | 2008-11-01 |
| AMG 102 in Combination With Mitoxantrone and Prednisone in Subjects With Previously Treated Castrate Resistant Prostate Cancer (NCT00770848) | Amgen | 2008-11-01 |
| Pilot Study Of Primary And Secondary Attention-Deficit/Hyperactivity Disorder Among Survivors Of Childhood Cancer (NCT01032811) | St. Jude Children's Research Hospital | 2008-10-01 |
| An Efficacy and Safety Study of Hydromorphone Hydrochloride (HCl) Oral Osmotic System (OROS) in the Reduction of Breakthrough Pain Medication Frequency in Participants With Cancer (NCT01006356) | Janssen Korea, Ltd., Korea | 2008-10-01 |
| Assessment of [18F]FLT-PET Imaging for Diagnosis and Prognosis of Brain Tumors (NCT00850278) | University Hospital, Caen | 2008-10-01 |
| Radiation, Cetuximab and Pemetrexed With or Without Bevacizumab in Locally Advanced Head and Neck Cancer (NCT00703976) | University of Pittsburgh | 2008-10-01 |
| Improvement of Self Management for Oncologic Patients With Pain (NCT00779597) | Martin-Luther-Universität Halle-Wittenberg | 2008-10-01 |
| A Study of a Live Intranasal Influenza Vaccine in Children With Cancer (NCT00906750) | St. Jude Children's Research Hospital | 2008-10-01 |
| Computerized Assessment for Patients With Cancer (NCT00852852) | Dana-Farber Cancer Institute | 2008-10-01 |
| Study of Patient Satisfaction With the Cancer Clinical Trial Experience (NCT00768976) | Summa Health System | 2008-10-01 |
| Effective Communication for Preventing and Responding to Oncology Adverse Events (NCT01871948) | University of Massachusetts, Worcester | 2008-10-01 |
| Patients' Knowledge and Understanding of Cancer Clinical Trials - a Study of Audio Recorded Information (NCT01502254) | Karolinska University Hospital | 2008-10-01 |
| Study of Cancers After Solid Organs Transplants (NCT00948883) | Assistance Publique - Hôpitaux de Paris | 2008-10-01 |
| Childhood Cancer Survivor Survey (NCT00788476) | M.D. Anderson Cancer Center | 2008-10-01 |
| Study of Denosumab in Subjects With Giant Cell Tumor of Bone (NCT00680992) | Amgen | 2008-09-09 |
| A Trial of ALB 109564(a) in Subjects With Advanced Solid Tumors (NCT00724100) | Albany Molecular Research, Inc. | 2008-09-01 |
| Testing an Optimal Model of Patient-Centered Cancer Care (NCT00921713) | Kaiser Permanente | 2008-09-01 |
| Efficacy Study of Maintenance IT-101 Therapy for Ovarian Cancer Patients. (NCT00753740) | NewLink Genetics Corporation | 2008-09-01 |
| A Dose Finding and Efficacy Study of the Tumour Targeting Human 131I-F16SIP Monoclonal Antibody in Patients With Cancer (NCT01240720) | Philogen S.p.A. | 2008-09-01 |
| Cancer Pain Single Nucleotide Polymorphisms (SNPs) (NCT00956878) | Erasmus Medical Center | 2008-09-01 |
| Thyroid Cancer in United Arab Emirates (NCT04763122) | Tawam Hospital | 2008-09-01 |
| Safety Study of XL147 (SAR245408), in Combination With Paclitaxel and Carboplatin in Adults With Solid Tumors (NCT00756847) | Sanofi | 2008-09-01 |
| Safety and Feasibility of Fasting While Receiving Chemotherapy (NCT00757094) | King Fahad Medical City | 2008-09-01 |
| Amitriptyline or Pregabalin to Treat Neuropathic Pain in Incurable Cancer (NCT00740571) | Radboud University Medical Center | 2008-09-01 |
| A Comparison of MBSR and CBT for the Treatment of Insomnia in Cancer (NCT01335776) | University of Calgary | 2008-09-01 |
| West Philadelphia Consortium Randomized Control Trial (NCT01299883) | University of Pennsylvania | 2008-08-01 |
| Safety, Efficacy, and Side Effects Study of Interventional Cryotherapy in the Pleural Space("ICE PLS") (NCT00747916) | CSA Medical, Inc. | 2008-08-01 |
| Epstein-Barr Virus and Cancer Risks (NCT06203314) | Sun Yat-sen University | 2008-08-01 |
| Oocyte Cryopreservation Study (Egg Banking) (NCT02396095) | University of Pennsylvania | 2008-08-01 |
| Evaluation of Predictive Proteic Profile on Mortality in the Acute Phase of Septic Shock in Cancer Patients (NCT00930085) | Institut Paoli-Calmettes | 2008-08-01 |
| DCE CT/MRI Scanning Study in Patients With Solid Tumours (AstraZeneca and Royal Marsden Hospital Imaging Study) (NCT00748891) | AstraZeneca | 2008-08-01 |
| Safety Study of XL765 (SAR245409) in Combination With Erlotinib in Adults With Solid Tumors (NCT00777699) | Sanofi | 2008-08-01 |
| Emergency Use of Donor Lymphocytes in Treating Patients Who Have Undergone Donor Stem Cell Transplant and Have Cytomegalovirus Infections (NCT00769613) | Milton S. Hershey Medical Center | 2008-08-01 |
| Non-Invasive Imaging of [18F]HX4 With Positron-Emission-Tomography (PET) (NCT00690053) | Maastricht Radiation Oncology | 2008-08-01 |
| Phase I, Open-label, Dose-escalation, Safety and PK Study of AZD6918 (NCT00733031) | AstraZeneca | 2008-08-01 |
| The Expression of Antigens in Bone Marrow Samples From Volunteering Donors. (NCT00706199) | GlaxoSmithKline | 2008-07-03 |
| Guangzhou Nutrition and Health Study (GNHS) (NCT03179657) | Sun Yat-sen University | 2008-07-01 |
| Phase I Study of Disulfiram and Copper Gluconate for the Treatment of Refractory Solid Tumors Involving the Liver (NCT00742911) | University of Utah | 2008-07-01 |
| Dose-escalating Study of LBH589 in Adult Patients With Advanced Solid Tumors (NCT00739414) | Novartis Pharmaceuticals | 2008-07-01 |
| A Trial of PDL192 in Subjects With Advanced Solid Tumors (NCT00738764) | Abbott | 2008-07-01 |
| Cohort Study to Identify Cancer Patients at High Risk of Venous Thromboembolism (NCT02095925) | Harry R. Buller | 2008-07-01 |
| Tetrodotoxin Open-label Efficacy and Safety Continuation Study (NCT00726011) | Wex Pharmaceuticals Inc. | 2008-07-01 |
| Sublingual Methadone for the Management of Cancer-related Breakthrough Pain in Outpatients (NCT00351715) | AHS Cancer Control Alberta | 2008-07-01 |
| Improving the Sleep of Cancer Patients Using an Internet-Based Program (NCT00716872) | University of Virginia | 2008-07-01 |
| PACE CALL: Weight Loss Study for Childhood Leukemia Survivors (NCT01253720) | Huang, Jeannie, M.D. | 2008-06-01 |
| Phase I Study of TAS-106 in Combo With Carboplatin (NCT00752011) | M.D. Anderson Cancer Center | 2008-06-01 |
| Carcinogenicity Study of Bupropion (NCT01077596) | GlaxoSmithKline | 2008-06-01 |
| Evaluation of AVE5026 in the Prevention of Venous Thromboembolism in Cancer Patients Undergoing Chemotherapy (NCT00694382) | Sanofi | 2008-06-01 |
| Study of a Multi-Antigen Therapeutic Vaccine in Patients With Metastatic Melanoma (NCT00613509) | Sanofi Pasteur, a Sanofi Company | 2008-06-01 |
| Relaxation and Heart Rate Variability (NCT00735618) | M.D. Anderson Cancer Center | 2008-06-01 |
| Protective Effect of Mangafodipir Against Oxaliplatin Neurotoxicity (NCT00727922) | Assistance Publique - Hôpitaux de Paris | 2008-06-01 |
| Safety Study of XL647 and XL147 Administered in Combination Daily in Adults With Solid Tumors (NCT00704392) | Exelixis | 2008-06-01 |
| Feasibility Study of a Web-Based Automated Self-Administered 24-hour Dietary Recall (ASA 24) and a Physical Activity 24-hour Recall (NCT01164254) | National Cancer Institute (NCI) | 2008-05-28 |
| The Biodistribution of 1-L-(2 Deoxy-2,- 18 Fluoroarabinofuranosyl) Cytosine ([18F]L-FAC) in Healthy Subjects and Patients With Cancer, Autoimmune and Inflammatory Diseases (NCT01180868) | Jonsson Comprehensive Cancer Center | 2008-05-01 |
| A Study of ARRY-380 in Patients With Advanced HER2+ Cancer (NCT00650572) | Seagen Inc. | 2008-05-01 |
| Safety Study of CALAA-01 to Treat Solid Tumor Cancers (NCT00689065) | Calando Pharmaceuticals | 2008-05-01 |
| Analysis of Palliative Surgery in View of Quality of Life and Prognosis (NCT00690391) | Johann Wolfgang Goethe University Hospital | 2008-05-01 |
| Safety Study of XL147 (SAR245408) in Combination With Erlotinib in Adults With Solid Tumors (NCT00692640) | Sanofi | 2008-05-01 |
| Communicating a Cancer Diagnosis-Current Methods and Their Effects (NCT00674804) | National Institutes of Health Clinical Center (CC) | 2008-04-24 |
| Dose Escalation Study With MK-2206 in Patients With Locally Advanced or Metastatic Solid Tumors (MK-2206-002) (NCT00670488) | Merck Sharp & Dohme LLC | 2008-04-15 |
| Corticosteroids for Cancer Pain (NCT00676936) | Norwegian University of Science and Technology | 2008-04-01 |
| Prognosis and Survival Estimates in Palliative Therapy (NCT00871520) | Heinrich-Heine University, Duesseldorf | 2008-04-01 |
| Safety & Efficacy Study of Subcutaneous Tetrodotoxin for Moderate to Severe Inadequately Controlled Cancer-related Pain (NCT00725114) | Wex Pharmaceuticals Inc. | 2008-04-01 |
| Study to Investigate AKT Inhibitor GSK690693 in Subjects With Relapsed or Refractory Hematologic Malignancies (NCT00666081) | GlaxoSmithKline | 2008-04-01 |
| A Study of AMG 820 in Subjects With Advanced Solid Tumors (NCT01444404) | AmMax Bio, Inc. | 2008-03-31 |
| Early Prediction of Therapeutic Response to Targeted Therapy in Stage IIIB/IV or Recurrent Lung Cancer Patients (NCT00708448) | University of Utah | 2008-03-28 |
| Multimedia Training for Family Caregivers in Use of Touch and Massage in Supportive Cancer Care (NCT00632398) | Collinge and Associates, Inc. | 2008-03-01 |
| Evaluation the Feasibility of the FOSTI Device (NCT00791609) | Optivasive Ltd. | 2008-03-01 |
| Low-dose Oral Clofarabine for the Treatment of IPSS INT-1, INT-2 or HIGH Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia (NCT00708721) | University of Utah | 2008-03-01 |
| Efficacy of Topotecan and Lapatinib in Early Recurrent Ovarian or Peritoneal Cancer (NCT00888810) | Centre Francois Baclesse | 2008-03-01 |
| Effect of rIL-21 on Metastases in Lymph Nodes in Melanoma Skin Cancer (NCT00601861) | Novo Nordisk A/S | 2008-02-13 |
| A Multicentre Study to Evaluate the Safety and Efficacy of AD 923 in Comparison to MSIR for the Treatment of CBP in Subjects (NCT00635063) | Sosei | 2008-02-01 |
| Procrit Versus Placebo to Determine Efficacy in Pre-Operative Major Surgical Oncology Operations (NCT00624312) | University of Louisville | 2008-02-01 |